CoMind Raises $60 Million to Advance Non-Invasive Brain Monitoring

London-based medical technology company CoMind has raised $60 million in new funding led by Plural, bringing its total financing to $102.5 million since its founding in 2018.

The company is developing a non-invasive device that uses low-powered infrared lasers to monitor cerebral blood flow, intracranial pressure, and autoregulation — crucial neurological metrics that are currently tracked using invasive procedures that involve drilling into the skull.

CoMind’s device aims to make brain monitoring safer, faster, and more accessible. Using optical and signal-processing techniques similar to those behind Lidar sensors in autonomous vehicles, it directs pulses of light through brain tissue and measures the returned signals to calculate changes in blood flow and oxygenation. This data could help clinicians detect complications earlier in patients with traumatic brain injury, stroke, or neurodegenerative conditions, and provide continuous monitoring during complex surgeries

James DacombeDealroom has a profile for this one. Try Dealroom → founded CoMind in 2018, when he was just 18 years old, inspired by family experiences with stroke and dementia. A self-taught programmer who left school at 16, he had previously secured early backing from LocalGlobeDealroom has a profile for this one. Try Dealroom → and a $100,000 Thiel FellowshipDealroom has a profile for this one. Try Dealroom →, and later attracted investment from Octopus Ventures in 2020.

CoMind has already completed clinical trials in London and Barcelona, and is now enrolling patients in the US for a third trial as it seeks FDADealroom has a profile for this one. Try Dealroom → approval ahead of a planned 2027 commercial launch. The company is partnering with Benchmark ElectronicsDealroom has a profile for this one. Try Dealroom → for manufacturing and development.

Sources:
CoMind
The Financial Times
Tech.eu
Silicon Canals
EU Startups

J.V.